Cargando...
Immune checkpoint inhibitors in cancer therapy
In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) whic...
Gardado en:
| Publicado en: | J Biomed Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Editorial Department of Journal of Biomedical Research
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163118/ https://ncbi.nlm.nih.gov/pubmed/28866656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.31.20160168 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|